Selected research
Industry Research
Milk Coagulants Industry Research Report 2026
Market perspective
The global Milk Coagulants market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Milk Coagulants is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Milk Coagulants is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Milk Coagulants is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Milk Coagulants include DuPont, Chr. Hansen Holding A/S, Enzyme Supplies Limited, Koninklijke DSM N.V., WalcoRen,, Fonterra Co-operative Group, Clarion Casein Ltd., Renco and Mahaan Foods Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Milk Coagulants market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Milk Coagulants Market by Company
DuPont
Chr. Hansen Holding A/S
Enzyme Supplies Limited
Koninklijke DSM N.V.
WalcoRen,
Fonterra Co-operative Group
Clarion Casein Ltd.
Renco
Mahaan Foods Ltd
AlindaVelco S.A.
Milk Coagulants Segment by Type
Liquid
Powder
Tablets
Milk Coagulants Segment by Application
Cheese
Dessert
Yogurt
Others
Milk Coagulants Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Milk Coagulants market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Milk Coagulants and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Milk Coagulants.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Milk Coagulants manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Milk Coagulants by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Milk Coagulants in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Liquid
- Powder
- Tablets
Applications
- Cheese
- Dessert
- Yogurt
- Others
Companies covered
- DuPont
- Chr. Hansen Holding A/S
- Enzyme Supplies Limited
- Koninklijke DSM N.V.
- WalcoRen,
- Fonterra Co-operative Group
- Clarion Casein Ltd.
- Renco
- Mahaan Foods Ltd
- AlindaVelco S.A.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Milk Coagulants Market Size (2021-2032)
- 2.2.2 Global Milk Coagulants Sales (2021-2032)
- 2.2.3 Global Milk Coagulants Market Average Price (2021-2032)
- 2.3 Milk Coagulants by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Liquid
- 2.3.3 Powder
- 2.3.4 Tablets
- 2.4 Milk Coagulants by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Cheese
- 2.4.3 Dessert
- 2.4.4 Yogurt
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Milk Coagulants Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Milk Coagulants Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Milk Coagulants Revenue of Manufacturers (2021-2026)
- 3.4 Global Milk Coagulants Average Price by Manufacturers (2021-2026)
- 3.5 Global Milk Coagulants Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Milk Coagulants, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Milk Coagulants, Product Type & Application
- 3.8 Global Manufacturers of Milk Coagulants, Established Date
- 3.9 Global Milk Coagulants Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 DuPont
- 4.1.1 DuPont Company Information
- 4.1.2 DuPont Business Overview
- 4.1.3 DuPont Milk Coagulants Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 DuPont Milk Coagulants Product Portfolio
- 4.1.5 DuPont Recent Developments
- 4.2 Chr. Hansen Holding A/S
- 4.2.1 Chr. Hansen Holding A/S Company Information
- 4.2.2 Chr. Hansen Holding A/S Business Overview
- 4.2.3 Chr. Hansen Holding A/S Milk Coagulants Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Chr. Hansen Holding A/S Milk Coagulants Product Portfolio
- 4.2.5 Chr. Hansen Holding A/S Recent Developments
- 4.3 Enzyme Supplies Limited
- 4.3.1 Enzyme Supplies Limited Company Information
- 4.3.2 Enzyme Supplies Limited Business Overview
- 4.3.3 Enzyme Supplies Limited Milk Coagulants Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Enzyme Supplies Limited Milk Coagulants Product Portfolio
- 4.3.5 Enzyme Supplies Limited Recent Developments
- 4.4 Koninklijke DSM N.V.
- 4.4.1 Koninklijke DSM N.V. Company Information
- 4.4.2 Koninklijke DSM N.V. Business Overview
- 4.4.3 Koninklijke DSM N.V. Milk Coagulants Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Koninklijke DSM N.V. Milk Coagulants Product Portfolio
- 4.4.5 Koninklijke DSM N.V. Recent Developments
- 4.5 WalcoRen,
- 4.5.1 WalcoRen, Company Information
- 4.5.2 WalcoRen, Business Overview
- 4.5.3 WalcoRen, Milk Coagulants Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 WalcoRen, Milk Coagulants Product Portfolio
- 4.5.5 WalcoRen, Recent Developments
- 4.6 Fonterra Co-operative Group
- 4.6.1 Fonterra Co-operative Group Company Information
- 4.6.2 Fonterra Co-operative Group Business Overview
- 4.6.3 Fonterra Co-operative Group Milk Coagulants Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Fonterra Co-operative Group Milk Coagulants Product Portfolio
- 4.6.5 Fonterra Co-operative Group Recent Developments
- 4.7 Clarion Casein Ltd.
- 4.7.1 Clarion Casein Ltd. Company Information
- 4.7.2 Clarion Casein Ltd. Business Overview
- 4.7.3 Clarion Casein Ltd. Milk Coagulants Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Clarion Casein Ltd. Milk Coagulants Product Portfolio
- 4.7.5 Clarion Casein Ltd. Recent Developments
- 4.8 Renco
- 4.8.1 Renco Company Information
- 4.8.2 Renco Business Overview
- 4.8.3 Renco Milk Coagulants Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Renco Milk Coagulants Product Portfolio
- 4.8.5 Renco Recent Developments
- 4.9 Mahaan Foods Ltd
- 4.9.1 Mahaan Foods Ltd Company Information
- 4.9.2 Mahaan Foods Ltd Business Overview
- 4.9.3 Mahaan Foods Ltd Milk Coagulants Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Mahaan Foods Ltd Milk Coagulants Product Portfolio
- 4.9.5 Mahaan Foods Ltd Recent Developments
- 4.10 AlindaVelco S.A.
- 4.10.1 AlindaVelco S.A. Company Information
- 4.10.2 AlindaVelco S.A. Business Overview
- 4.10.3 AlindaVelco S.A. Milk Coagulants Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 AlindaVelco S.A. Milk Coagulants Product Portfolio
- 4.10.5 AlindaVelco S.A. Recent Developments
5 Global Milk Coagulants Market Scenario by Region
- 5.1 Global Milk Coagulants Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Milk Coagulants Sales by Region: 2021-2032
- 5.2.1 Global Milk Coagulants Sales by Region: 2021-2026
- 5.2.2 Global Milk Coagulants Sales by Region: 2027-2032
- 5.3 Global Milk Coagulants Revenue by Region: 2021-2032
- 5.3.1 Global Milk Coagulants Revenue by Region: 2021-2026
- 5.3.2 Global Milk Coagulants Revenue by Region: 2027-2032
- 5.4 North America Milk Coagulants Market Facts & Figures by Country
- 5.4.1 North America Milk Coagulants Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Milk Coagulants Sales by Country (2021-2032)
- 5.4.3 North America Milk Coagulants Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Milk Coagulants Market Facts & Figures by Country
- 5.5.1 Europe Milk Coagulants Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Milk Coagulants Sales by Country (2021-2032)
- 5.5.3 Europe Milk Coagulants Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Milk Coagulants Market Facts & Figures by Country
- 5.6.1 Asia Pacific Milk Coagulants Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Milk Coagulants Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Milk Coagulants Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Milk Coagulants Market Facts & Figures by Country
- 5.7.1 South America Milk Coagulants Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Milk Coagulants Sales by Country (2021-2032)
- 5.7.3 South America Milk Coagulants Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Milk Coagulants Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Milk Coagulants Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Milk Coagulants Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Milk Coagulants Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Milk Coagulants Sales by Type (2021-2032)
- 6.1.1 Global Milk Coagulants Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Milk Coagulants Sales Market Share by Type (2021-2032)
- 6.2 Global Milk Coagulants Revenue by Type (2021-2032)
- 6.2.1 Global Milk Coagulants Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Milk Coagulants Revenue Market Share by Type (2021-2032)
- 6.3 Global Milk Coagulants Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Milk Coagulants Sales by Application (2021-2032)
- 7.1.1 Global Milk Coagulants Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Milk Coagulants Sales Market Share by Application (2021-2032)
- 7.2 Global Milk Coagulants Revenue by Application (2021-2032)
- 7.2.1 Global Milk Coagulants Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Milk Coagulants Revenue Market Share by Application (2021-2032)
- 7.3 Global Milk Coagulants Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Milk Coagulants Value Chain Analysis
- 8.1.1 Milk Coagulants Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Milk Coagulants Production Mode & Process
- 8.2 Milk Coagulants Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Milk Coagulants Distributors
- 8.2.3 Milk Coagulants Customers
9 Global Milk Coagulants Analyzing Market Dynamics
- 9.1 Milk Coagulants Industry Trends
- 9.2 Milk Coagulants Industry Drivers
- 9.3 Milk Coagulants Industry Opportunities and Challenges
- 9.4 Milk Coagulants Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst